Checkmate Pharmaceuticals Inc. (CMPI) Social Stream



Checkmate Pharmaceuticals Inc. (CMPI): $10.50

0.02 (+0.19%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add CMPI to Watchlist
Sign Up

CHECKMATE PHARMACEUTICALS INC (CMPI) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering CHECKMATE PHARMACEUTICALS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-24 2 $19 $7 $13 $10.5 23.81%
2022-03-30 3 $19 $6 $11.333 $10.5 7.93%

The Trend in the Analyst Price Target


CMPI's average price target has moved down $11.34 over the prior 39 weeks.

CMPI reports an average of 283.26% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-02 4 32 19 25.00 6.69 273.69%
2021-07-02 4 29 19 22.67 5.86 286.86%
2021-08-05 4 29 19 22.67 5.26 330.99%
2021-08-17 4 29 19 22.33 5.00 346.6%
2021-10-06 2 19 7 13.00 4.29 203.03%

CMPI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, CHECKMATE PHARMACEUTICALS INC's number of analysts covering the stock is higher than 18.82% of them.
  • In the context of all US stocks, CHECKMATE PHARMACEUTICALS INC's variance in analysts' estimates is lower than -174.82% of them.
  • CHECKMATE PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 22.06% of Pharmaceutical Products stocks.
  • In the context of Healthcare stocks, CHECKMATE PHARMACEUTICALS INC's average analyst price target is greater than 60.99% of them.

In the Pharmaceutical Products industry, CLLS, CHRS, and CGEN are the three stocks most similar to CHECKMATE PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

Is CMPI a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!